−100.42 M USD
0.00 USD
24.03 M
About Maze Therapeutics, Inc.
Sector
CEO
Jason V. Coloma
Headquarters
San Francisco
Website
Founded
2017
FIGI
BBG00NHJHS27
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes Compass platform, which allows to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 28, 2019 and is headquartered in San Francisco, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MAZE is 13.25 USD — it has decreased by −5.96% in the past 24 hours. Watch Maze Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Maze Therapeutics, Inc. stocks are traded under the ticker MAZE.
MAZE stock has fallen by −6.95% compared to the previous week, the month change is a −6.95% fall, over the last year Maze Therapeutics, Inc. has showed a −17.80% decrease.
MAZE reached its all-time high on Jan 31, 2025 with the price of 17.00 USD, and its all-time low was 15.25 USD and was reached on Jan 31, 2025. View more price dynamics on MAZE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Maze Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
MAZE net income for the last quarter is −2.43 M USD, while the quarter before that showed −26.58 M USD of net income which accounts for 90.87% change. Track more Maze Therapeutics, Inc. financial stats to get the full picture.
No, MAZE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MAZE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Maze Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.